STKLD1 Antibody (6G9): sc-134290

STKLD1 Antibody (6G9) is a mouse monoclonal IgG2a kappa light chain antibody that detects STKLD1 protein of human origin by western blotting (WB), immunoprecipitation (IP), and enzyme-linked immunosorbent assay (ELISA). Anti-STKLD1 antibody (6G9) is available as a non-conjugated format, providing researchers with a reliable tool for studying STKLD1. STKLD1 protein is primarily located in the cytoplasm and plays a crucial role in cellular signaling pathways that regulate cell growth and differentiation. Understanding STKLD1 localization is vital, as misregulation can lead to various developmental disorders and diseases, including those affecting sexual differentiation. Chromosome 9, where STKLD1 gene is located, is known for its significant role in gender determination, and alterations in this region can result in conditions such as male-to-female sex reversal. Chromosome 9 is associated with several other critical genes, including those linked to hereditary hemorrhagic telangiectasia and familial dysautonomia, highlighting the importance of studying STKLD1 in the context of broader genetic interactions. STKLD1 (6G9) antibody, with specific reactivity to human STKLD1, serves as an essential resource for researchers investigating the functional implications of STKLD1 in health and disease.

Alexa Fluor^® is a trademark of Molecular Probes Inc., OR., USA

LI-COR^® and Odyssey^® are registered trademarks of LI-COR Biosciences

STKLD1 Antibody (6G9) References:

1. The protein kinase complement of the human genome.  |  Manning, G., et al. 2002. Science. 298: 1912-34. PMID: 12471243
2. BCR-ABL activates STAT3 via JAK and MEK pathways in human cells.  |  Coppo, P., et al. 2006. Br J Haematol. 134: 171-9. PMID: 16846476
3. BCR and its mutants, the reciprocal t(9;22)-associated ABL/BCR fusion proteins, differentially regulate the cytoskeleton and cell motility.  |  Zheng, X., et al. 2006. BMC Cancer. 6: 262. PMID: 17090304
4. Patterns of somatic mutation in human cancer genomes.  |  Greenman, C., et al. 2007. Nature. 446: 153-8. PMID: 17344846
5. Gene expression fingerprinting for human hereditary hemorrhagic telangiectasia.  |  Fernandez-L, A., et al. 2007. Hum Mol Genet. 16: 1515-33. PMID: 17420163
6. Phenotypic and cytogenetic spectrum of 9p trisomy.  |  Temtamy, SA., et al. 2007. Genet Couns. 18: 29-48. PMID: 17515299
7. Potential role of tubulin acetylation and microtubule-based protein trafficking in familial dysautonomia.  |  Gardiner, J., et al. 2007. Traffic. 8: 1145-9. PMID: 17605759
8. Pulmonary vascular manifestations of hereditary hemorrhagic telangiectasia (rendu-osler disease).  |  Cottin, V., et al. 2007. Respiration. 74: 361-78. PMID: 17641482
9. Atypical BCR-ABL mRNA transcripts in adult acute lymphoblastic leukemia.  |  Burmeister, T., et al. 2007. Haematologica. 92: 1699-702. PMID: 18055996